About Deoxi Biotecnologia
Deoxi Biotecnologia is an Agriculture company based in Sao Paulo (Brazil) founded in 2008, and was acquired by Neogen in April 2016. Animal genomics laboratory services are provided worldwide. Its chief executive, as recorded, is John Adent. Its focus areas include Food and Agriculture and Services for Livestock Farms.
Company details
Deoxi Biotecnologia was established in 2008 in Sao Paulo, Brazil. Services in animal genomics are delivered through laboratory operations within the biotechnology sector. Core activities encompass genetic analysis and testing for livestock and veterinary applications. The company is led by CEO John Adent. Focus remains on supporting agricultural and research needs in South America, with domain deoxi.com.br utilized for outreach.
- Headquarters Sao Paulo, Brazil
- Stage Acquired
- SectorsAgriculture
- Website deoxi.com.br
- Acquired by Neogen (Apr 2016)
Investors in Deoxi Biotecnologia
Deoxi Biotecnologia has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Neogen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing | 1982 | neogen.com | Lansing, United States |
Investor details for Deoxi Biotecnologia
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Deoxi Biotecnologia
1 people are tracked at Deoxi Biotecnologia (1 in leadership).
| Name | Role | Group |
|---|---|---|
John Adent | CEO | Leadership |
Complete people profiles for Deoxi Biotecnologia
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Deoxi Biotecnologia
2 dated milestones of Deoxi Biotecnologia across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Deoxi Biotecnologia is founded.
- Exit Acquired by Neogen.
Web traffic of Deoxi Biotecnologia
Websites that share an audience with Deoxi Biotecnologia (deoxi.com.br).
Websites whose visitors overlap most with Deoxi Biotecnologia. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| google.com | 100% | 85.8B | #1 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Deoxi Biotecnologia
Deoxi Biotecnologia was founded in 2008.
Deoxi Biotecnologia is headquartered in Sao Paulo, Brazil.
John Adent is the CEO of Deoxi Biotecnologia, as recorded in our data.
Deoxi Biotecnologia was established in 2008 in Sao Paulo, Brazil. Services in animal genomics are delivered through laboratory operations within the biotechnology sector. Core activities encompass genetic analysis and testing for livestock and veterinary applications. The company is led by CEO John Adent. Focus remains on supporting agricultural and research needs in South America, with domain deoxi.com.br utilized for outreach.
Deoxi Biotecnologia has 1 investor. Key investors include Neogen.
Yes. Deoxi Biotecnologia was acquired by Neogen in April 2016.